Cargando…

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa

OBJECTIVE: To describe immunologic, virologic, and clinical HIV disease progression by HIV-1 subtype among Africans with well documented estimated dates of HIV infection (EDIs). DESIGN: Prospective cohort. METHODS: Adults and youth with documented HIV-1 infection in the past 12 months were recruited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amornkul, Pauli N., Karita, Etienne, Kamali, Anatoli, Rida, Wasima N., Sanders, Eduard J., Lakhi, Shabir, Price, Matt A., Kilembe, William, Cormier, Emmanuel, Anzala, Omu, Latka, Mary H., Bekker, Linda-Gail, Allen, Susan A., Gilmour, Jill, Fast, Patricia E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2013
Materias:	Epidemiology and Social
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815107/ https://www.ncbi.nlm.nih.gov/pubmed/24113395 http://dx.doi.org/10.1097/QAD.0000000000000012

Ejemplares similares

Prediction of extended high viremia among newly HIV-1-infected persons in sub-Saharan Africa
por: Powers, Kimberly A., et al.
Publicado: (2018)

Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa
por: Pantazis, Nikos, et al.
Publicado: (2012)

Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa
por: Sanders, Eduard J., et al.
Publicado: (2017)

Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries
por: Wall, Kristin M., et al.
Publicado: (2017)

Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions
por: Li, Xuelin, et al.
Publicado: (2014)

Creating an African HIV Clinical Research and Prevention Trials Network: HIV Prevalence, Incidence and Transmission
por: Kamali, Anatoli, et al.
Publicado: (2015)

Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection
por: Price, Matt A, et al.
Publicado: (2019)

Cohort Profile: IAVI’s HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery
por: Price, Matt A, et al.
Publicado: (2020)

P06-08. Building an African HIV preventive trial network
por: Price, MA, et al.
Publicado: (2009)

Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
por: Landais, Elise, et al.
Publicado: (2016)

CD4:CD8 lymphocyte ratio as a quantitative measure of immunologic health in HIV-1 infection: findings from an African cohort with prospective data
por: Tang, Jianming, et al.
Publicado: (2015)

High Transmitter CD4+ T-Cell Count Shortly after the Time of Transmission in a Study of African Serodiscordant Couples
por: Karita, Etienne, et al.
Publicado: (2015)

Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda
por: Mayanja, Yunia, et al.
Publicado: (2023)

An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration
por: Olson, Ashley D., et al.
Publicado: (2014)

VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120
por: Smith, S. Abigail, et al.
Publicado: (2019)

Failure of A Novel, Rapid Antigen and Antibody Combination Test to Detect Antigen-Positive HIV Infection in African Adults with Early HIV Infection
por: Kilembe, William, et al.
Publicado: (2012)

Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth
por: Smith, S. Abigail, et al.
Publicado: (2016)

CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa
por: Karita, Etienne, et al.
Publicado: (2009)

Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials
por: Stevens, Wendy, et al.
Publicado: (2008)

Uptake and tolerability of repeated mucosal specimen collection in two Phase 1 AIDS preventive vaccine trials in Kenya
por: Mutua, G, et al.
Publicado: (2012)

Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial
por: Mpendo, Juliet, et al.
Publicado: (2020)

HIV disease progression compared by linkage status in Rwanda and Zambia
por: Kilembe, W, et al.
Publicado: (2012)

Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa
por: Ngongo, BP, et al.
Publicado: (2012)

HIV Incidence and Risk Factors for Acquisition in HIV Discordant Couples in Masaka, Uganda: An HIV Vaccine Preparedness Study
por: Ruzagira, Eugene, et al.
Publicado: (2011)

A mixed-methods assessment of understanding (AoU) tool for AIDS vaccine trials in sub-Saharan Africa: results from a pilot study
por: Lindegger, G, et al.
Publicado: (2012)

Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya
por: Omosa-Manyonyi, Gloria, et al.
Publicado: (2014)

Viral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial
por: Campbell, Mary S., et al.
Publicado: (2011)

Immune correlates of Mycobacterium Tuberculosis patients in Zambia stratified by HIV serostatus and level of immunity-a cross-sectional analytical laboratory based study
por: Lungu, Patrick, et al.
Publicado: (2022)

A comparison of vitamin D and cathelicidin (LL-37) levels between patients with active TB and their healthy contacts in a high HIV prevalence setting: a prospective descriptive study
por: Lungu, Patrick Saili, et al.
Publicado: (2021)

Protective effect of KIR3DS1 in asymptomatic HIV-1 seroconverters towards AIDS
por: Stalinraja, M, et al.
Publicado: (2012)

Effect of Seasonal Variation on Adult Clinical Laboratory Parameters in Rwanda, Zambia, and Uganda: Implications for HIV Biomedical Prevention Trials
por: Ruzagira, Eugene, et al.
Publicado: (2014)

Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy
por: Huang, Xiaojie, et al.
Publicado: (2016)

Upregulation of PTPRC and Interferon Response Pathways in HIV-1 Seroconverters Prior to Infection
por: Li, Yunqi, et al.
Publicado: (2023)

A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome
por: Hassan, Amin S, et al.
Publicado: (2021)

Prevalence and risk factors of three curable sexually transmitted infections among women in Nairobi, Kenya
por: Maina, Anne Njeri, et al.
Publicado: (2016)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults
por: Mpendo, Juliet, et al.
Publicado: (2015)

Detection of a Single Identical Cytomegalovirus (CMV) Strain in Recently Seroconverted Young Women
por: Murthy, Suchetha, et al.
Publicado: (2011)

Immune Status and Epidemiological Characteristics of Human Immunodeficiency Virus Seroconverters in Korea, 1999–2009
por: Wang, Jin-Sook, et al.
Publicado: (2012)

Brief Report: Sexual Risk Behaviors of HIV Seroconverters in the US Army, 2012–2014
por: Hakre, Shilpa, et al.
Publicado: (2015)

Cultured enzyme-linked immunospot assay (ELISPOT) enhances detection of low HIV-specific immune responses in exposed seronegative individuals in Kenya
por: Muturi, Margaret, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ddlnsr4spst05e7g6qr5gakdk0